Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
50%
Ph phase_1
2
33%
Ph phase_2
1
17%

Phase Distribution

2

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (33.3%)
Phase 21 (16.7%)
Phase 33 (50.0%)

Trials by Status

completed583%
not_yet_recruiting117%

Recent Activity

0 active trials
Showing 5 of 6
not_yet_recruitingphase_3

Efficacy and Safety of VER-01 in the Treatment of Patients With Radicular Chronic Low Back Pain

NCT06956014
completedphase_2

Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

NCT06475001
completedphase_3

Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain

NCT05610813
completedphase_3

Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

NCT04940741
completedphase_1

Food Effect Study of VER-01 in Healthy Volunteers

NCT04930796
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06956014Phase 3

Efficacy and Safety of VER-01 in the Treatment of Patients With Radicular Chronic Low Back Pain

Not Yet Recruiting
NCT06475001Phase 2

Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

Completed
NCT05610813Phase 3

Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain

Completed
NCT04940741Phase 3

Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

Completed
NCT04930796Phase 1

Food Effect Study of VER-01 in Healthy Volunteers

Completed
NCT04930809Phase 1

Single and Multiple Dose Study of VER-01 in Healthy Volunteers

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6